Innovative TechnologiesWomen are showing willingness to pay for ESTA's innovative technologies, paying out-of-pocket and forgoing competitors' warranties while paying a premium for breast preservation with Preservé.
Market Share GrowthMotiva is expected to have 14% market share in 2025, 26% market share in 2026 and 32% market share in 2027.
Minimally Invasive PlatformESTA announced expectations for its minimally invasive platform to generate at least $30M in revenue in 2026, with continued TAM expansion on both a dollar and procedure basis.